DCF — MYMICHIGAN MEDICAL CENTER MIDLAND
Enterprise Value: $-818.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-818.9M
Enterprise Value
$-260.5M
PV of Cash Flows
$-558.5M
PV of Terminal Value
$-899.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $554.0M | $-50.3M | -9.0% | $-73.7M | $-67.0M |
| Year 2 | $570.6M | $-46.1M | -8.0% | $-70.2M | $-58.0M |
| Year 3 | $587.7M | $-41.6M | -7.0% | $-66.4M | $-49.9M |
| Year 4 | $605.4M | $-39.8M | -7.0% | $-65.4M | $-44.7M |
| Year 5 | $623.5M | $-39.4M | -6.0% | $-65.8M | $-40.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-818.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$537.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0957163770099842
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5